Navigation Links
Coroners wrong to say no to post-mortem tissue collection, academics argue
Date:5/9/2011

The creation of a post-mortem tissue archive for a study of the human form of mad cow disease failed because of a "misguided" refusal by coroners to participate.

The Coroners' Society of England and Wales (CSEW) did not recognise its "moral obligation to protect public health" from potential new risks associated with variant Creutzfeldt-Jakob disease (vCJD) when it decided not to allow the collection of tissue from autopsies.

That is the conclusion of a paper co-written by a researcher at the London School of Hygiene & Tropical Medicine, which has been published online and is set to appear in a forthcoming edition of the journal Public Health.

The authors say they believe the reasons given by the CSEW were insufficient to justify not taking part in the study and call for a wider review of the role of coroners in future public health measures. They also criticise the move by the Government to abolish the proposed position of Chief Coroner as part of the Public Bodies Bill which is set to have its final reading in the House of Lords on Monday May 9.

Until 2003, all cases of vCJD a fatal brain-wasting disease in humans were caused by exposure to bovine spongiform encephalopathy (BSE) in the diet.

More recently a small number of infections are thought to have resulted from blood transfusions from donors who did not know they were infected with vCJD.

It is also believed that iatrogenic transmission may occur as a result of contaminated surgical instruments a concern which prompted hospitals in Essex and Wales to contact patients earlier this year.

In response to the evidence that vCJD has the potential to emerge as a second-wave infection resulting from human-to-human transmission, the Health Protection Agency (HPA) attempted to create a post-mortem tissue archive.

Its aim was to determine the prevalence of abnormal prion protein, which is a marker for vCJD infection, in the UK in order to determine the efficacy of current precautionary measures and to determine if further measures might be necessary.

But following a protracted correspondence with the Chief Medical Officer, the CSEW declined to participate, citing issues including its legality, cost and feasibility, concluding that taking part would "adversely affect the independence of the coronial service and would further erode public confidence".

According to the authors of the paper, "declining to participate in this study was misguided and illustrates a considerable failure by the CSEW to recognise coroners' moral obligation to protect public health".

They add: "The protection of public health is an appropriate and vital obligation of government officials as such protection helps to ensure the conditions necessary for individuals and groups to live healthy and safe lives."

Lead author Catherine McGowan, based in the Faculty of Public Health and Policy at LSHTM, said: "A Chief Coroner one with a clear understanding of the role of the coroner's service in protecting the public good should be able to facilitate this type of public health survey in the future".

"Despite the valiant attempts of the House of Lords to save the proposed position of Chief Coroner from abolition under the Public Bodies Bill, the position is now likely to be axed by the House of Commons. This seems a grave mistake."


'/>"/>

Contact: Paula Fentiman
paula.fentiman@lshtm.ac.uk
020-792-72802
London School of Hygiene & Tropical Medicine
Source:Eurekalert

Related medicine news :

1. Neuronal migration errors: Right cells, wrong place
2. Surgery on Wrong Patients, Surgical Sites Persists, Study Finds
3. Study documents wrong-site, wrong-patient procedure errors
4. Cant focus? Maybe its the wrong time of month
5. Some Older ER Patients Are Getting the Wrong Medicines, U-M Study Finds
6. Some older ER patients are getting the wrong medicines, U-M study finds
7. Cleveland Medical Malpractice Attorney Obtains Settlement in Wrongful Death Case
8. Health Groups Ask Supreme Court to Authorize Financial Penalties on Tobacco Companies for Decades of Wrongdoing
9. Molecular Signatures in Post-Mortem Brain Tissue of Younger Individuals at High Risk for Alzheimer's Disease
10. Tissue spacers reduce risk of rectal injury for prostate cancer patients
11. Rice wins $1.2 million for heart-valve tissue research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... York, NY (PRWEB) , ... February 10, 2016 , ... ... campaign to celebrate and raise awareness of Nestlé KITKAT as the first global confectionery ... the lives of cocoa farmers and the quality of their product, through activities that ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... a full-service health care communications company offering education, research and medical media, ... practitioners and specialists working in infectious diseases. , As the all-inclusive resource ...
(Date:2/10/2016)... ... February 10, 2016 , ... MetLoop CEO Jay ... 2.0 version at the International Roofing Expo in Orlando, Florida on February 17-19. ... most advanced weather technology in the hands of consumers, roofing contractors, manufacturers and ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... and Video Remote Interpreting (VRI) within Healthcare, recently partnered with Heart City ... interpreting (VRI). , For nearly 23 years, Heart City Health Center has provided ...
(Date:2/10/2016)... ... February 10, 2016 , ... Compliancy Group LLC is pleased ... professionals throughout the country. The Guard was specifically designed to handle each element ... training, regulatory updates, and compliance coaching. , In addition to meeting the compliance ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... Feb. 10, 2016  Fotona, based in the U.S. and ... its new ST PRO Lightwalker dental laser at the upcoming ... from 25-27 February, 2016 in booth #4815. The ST PRO ... with many of the features of the award winning, industry ... PRO competitive price will be very attractive to many dentists ...
(Date:2/10/2016)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), today ... and full year ended December 31, 2015. ... transformational year for Vanda with the continued growth of ... of HETLIOZ for Non-24," said Mihael H. Polymeropoulos, M.D., ... our U.S. product portfolio builds on this success and ...
(Date:2/10/2016)... report from business intelligence provider GBI Research - Alzheimer,s Disease Therapeutics Market ... double from just under $5 billion in 2014 to an estimated $10.4 billion ... Canada , France , Germany ... and Japan , and will primarily be driven by increased ... France , Germany , Italy ...
Breaking Medicine Technology: